Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: CYPROTEX US LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-18 to 2024-09-17
Current total value of award: $56313
Description: SERVICES FOR THE CHARACTERIZATION OF ABSORPTION, DISTRIBUTION, METABOLISM, EXCRETION, AND TOXICITY (ADMET) PROPERTIES OF SMALL-MOLECULE DRUG CANDIDATES USING STANDARDIZED IN VITRO METHODS IN SUPPORT OF THE HHS, NIH, NATIONAL CANCER INSTITUTE (NCI), D